Mirati Therapeutics Inc

NASDAQ:MRTX   4:00:00 PM EDT
91.38
+2.62 (+2.95%)
4:02:49 PM EDT: $91.38 0.00 (0.00%)
Earnings Announcements

Mirati Therapeutics Reports Q3 2022 Results

Published: 11/08/2022 22:43 GMT
Mirati Therapeutics Inc (MRTX) - Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates.
Qtrly Revenue $5.4 Million Versus $71.8 Million.
Qtrly Loss per Share $3.09.
Q3 Earnings per Share View $-3.48 -- Refinitiv Ibes Data (analyst estimates).
Q3 Revenue View $1.3 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $2.42 Million
Adjusted EPS is expected to be -$3.55

Next Quarter Revenue Guidance is expected to be $11.47 Million
Next Quarter EPS Guidance is expected to be -$3.31

More details on our Analysts Page.